FAKTOR-OPTIONSSCHEIN - BIO-RAD LABORATORIES Stock

Certificat

DE000SN7D2Q1

Market Closed - Börse Stuttgart 11:33:45 2024-06-14 am EDT
16.16 EUR +1.70% Intraday chart for FAKTOR-OPTIONSSCHEIN - BIO-RAD LABORATORIES
Current month+4.53%
1 month+10.76%
Date Price Change
24-06-14 16.16 +1.70%
24-06-13 15.89 +4.68%
24-06-12 15.18 -4.53%
24-06-11 15.9 +3.31%
24-06-10 15.39 +1.05%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 11:33 am EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying BIO-RAD LABORATORIES, INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SN7D2Q
ISINDE000SN7D2Q1
Date issued 2022-07-28
Strike 536.1 $
Maturity Unlimited
Parity 1 : 1
Emission price 10.54
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 39.29
Lowest since issue 4.99
Spread 0.56
Spread %3.36%

Company Profile

Bio-Rad Laboratories, Inc. is specialized in the development, manufacturing and marketing of products used in life sciences research, clinical diagnostics and analytical chemistry. Net sales break down by activity as follows: - manufacture of clinical diagnostic tests and automated test systems (51.8%). The group also offers test kits, quality control systems and related IT systems; - manufacture of reagents, equipment and instruments for biological research (48.1%): for the separation, identification and purification of chemical and biological substances (proteins, nucleic acids, bacteria, etc.) for the proteomics, genomics research, biopharmaceuticals, cell biology and food safety markets; - other (0.1%): in particular, manufacturing of analytical instruments. At the end of 2022, the Group has 16 production sites in the United States (5), Germany (3), France (2), China (2), Poland, the United Kingdom, Switzerland and Singapore. Net sales are distributed geographically as follows: the United States (41.2%), Europe (30.4%), Asia (22.8%) and other (5.6%).
Sector
-
More about the company

Ratings for Bio-Rad Laboratories, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Bio-Rad Laboratories, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
282.3 USD
Average target price
368.8 USD
Spread / Average Target
+30.66%
Consensus